ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
1 story in the last 7 days
The latest biopharmaceutical news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks biopharmaceutical across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
Symbiotec Pharmalab's Rs 1,757 crore IPO opens August 24, 2026, with a price band of Rs 938-988 per share. Minimum bid is 15 shares, requiring Rs 14,820 at the upper end. The issue closes August 27 and lists on BSE and NSE.
Summaries by ByteBrief